State VA
Clinical Trials in Virginia
Recruiting clinical trials with at least one study location in Virginia. Data updated daily from ClinicalTrials.gov.
Top Conditions in Virginia
NCT06872125 Phase 3
Recruiting
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevu...
Condition
Dravet Syndrome
Enrollment
170 pts
Location
United States, Japan, United Kingdom
Sponsor
Stoke Therapeutics, Inc
NCT05836987 Phase 3
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial F...
Condition
Atrial Fibrillation
Enrollment
5,350 pts
Location
United States
Sponsor
Johns Hopkins University
NCT05897320 Phase 3
Recruiting
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Condition
Episodic Migraine
Enrollment
315 pts
Location
United States, Argentina, Canada
Sponsor
H. Lundbeck A/S
NCT02598349 Phase 2
Recruiting
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperabl...
Condition
Pancreatic Cancer
Enrollment
60 pts
Location
United States
Sponsor
Proton Collaborative Group
NCT04380038 Phase 4
Recruiting
Viral Infection in Asthma (VIA) Study
Condition
Asthma
Enrollment
60 pts
Location
United States
Sponsor
University of Virginia
NCT07184996 Phase 3
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Partic...
Condition
Ulcerative Colitis
Enrollment
980 pts
Location
United States, Canada, Japan
Sponsor
Sanofi
NCT07285213 Phase 2
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Ant...
Condition
Clostridioides Difficile Infection
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT03168659 N/A
Recruiting
CardioFocus HeartLight Post-Approval Study
Condition
Atrial Fibrillation
Enrollment
250 pts
Location
United States
Sponsor
CardioFocus
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05875220 N/A
Recruiting
Organic Compounds and Postoperative Delirum
Condition
Identify Postoperative Delirium Using Exhaled Gas Patterns
Enrollment
150 pts
Location
United States
Sponsor
University of Virginia
NCT05550896 N/A
Recruiting
Platelet Adhesion in the Pathobiology of Aortic Stenosis
Condition
Aortic Valve Stenosis
Enrollment
65 pts
Location
United States
Sponsor
University of Virginia
NCT04239703 N/A
Recruiting
Trifecta-Kidney cfDNA-MMDx Study
Condition
Kidney Transplant Rejection
Enrollment
300 pts
Location
United States, Australia, Canada
Sponsor
University of Alberta
NCT04419480 N/A
Recruiting
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Tri...
Condition
Cardiogenic Shock
Enrollment
40 pts
Location
United States
Sponsor
Inova Health Care Services
NCT03493425 Phase 2
Recruiting
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Thera...
Condition
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
Enrollment
82 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT06541262 Phase 1, Phase 2
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory...
Condition
Neuroblastoma
Enrollment
104 pts
Location
United States, Canada
Sponsor
Milton S. Hershey Medical Cent
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT05329103 Phase 1
Recruiting
A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
65 pts
Location
United States
Sponsor
Peel Therapeutics Inc
NCT04592445 N/A
Recruiting
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having H...
Condition
Heart Failure With Preserved Ejection Fraction (HFpEF
Enrollment
150 pts
Location
United States
Sponsor
Axon Therapies, Inc.
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT07106762 Phase 2, Phase 3
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Me...
Condition
Urothelial Cancer
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06781983 Phase 1
Recruiting
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
Condition
Advanced or Metastatic Solid Tumors
Enrollment
145 pts
Location
United States, France
Sponsor
Innate Pharma
NCT05112601 Phase 2
Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System...
Condition
Endometrial Adenocarcinoma
Enrollment
81 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06664619 Phase 3
Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of F...
Condition
Asthma
Enrollment
724 pts
Location
United States, Argentina, Bulgaria
Sponsor
Teva Branded Pharmaceutical Pr